Inhibition of SLC1A5 sensitizes colorectal cancer to cetuximab-Reference-Cited by-同舟云学术

Inhibition of SLC1A5 sensitizes colorectal cancer to cetuximab

Published:2018-02-09 Issue:12 Volume:142 Page:2578-2588
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Ma Huanrong¹,Wu Zhenzhen¹,Peng Jianjun²,Li Yang¹,Huang Hongxiang¹,Liao Yi¹,Zhou Minyu¹,Sun Li¹,Huang Na¹,Shi Min¹^ORCID,Bin Jianping³,Liao Yulin³,Rao Jinjun⁴,Wang Lin¹,Liao Wangjun¹^ORCID

Affiliation:

1. Department of Oncology; Nanfang Hospital, Southern Medical University; Guangzhou China

2. Department of Gastrointestinal Surgery Center; The First Affiliated Hospital of Sun Yat-sen University; Guangzhou China

3. Department of Cardiology; Nanfang Hospital, Southern Medical University; Guangzhou China

4. Key laboratory of new drug screening of Guangdong province, School of Pharmaceutical Sciences; Southern Medical University; Guangzhou China

Funder

National Natural Science Foundation of China

CSCO-Merck Serono Oncology Research Fund

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.31274/fullpdf

Reference38 articles.

1. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions;Soerjomataram;Lancet,2012

2. Recent developments in the treatment of metastatic colorectal cancer;Loree;Ther Adv Med Oncol,2017

3. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer;Cutsem;N Engl J Med,2009

4. Resistance to anti-EGFR therapy in colorectal cancer: from heterogeneity to convergent evolution;Misale;Cancer Disc,2014

5. New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?;Bronte;Oncotarget,2015

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MCT1-dependent lactate recycling is a metabolic vulnerability in colorectal cancer cells upon acquired resistance to anti-EGFR targeted therapy;Cancer Letters;2024-08

2. Amino acid transporters within the solute carrier superfamily: Underappreciated proteins and novel opportunities for cancer therapy;Molecular Metabolism;2024-06

3. The cross talk of ubiquitination and chemotherapy tolerance in colorectal cancer;Journal of Cancer Research and Clinical Oncology;2024-03-23

4. Targeting Solute Carrier Transporters (SLCs) as a Therapeutic Target in Different Cancers;Diseases;2024-03-21

5. High-Throughput Mass Spectrometry Analysis of N-Glycans and Protein Markers after FUT8 Knockdown in the Syngeneic SW480/SW620 Colorectal Cancer Cell Model;Journal of Proteome Research;2024-03-20